Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT05204212

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

In the proposed event driven trial, LAA closure devices will be compared in a 1:1 randomization to best medical care in AF patients at high risk of stroke and b…

Germany430 participantsStarted 2022-03-28

Treatment: Left Atrial Appendage closure

Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

All recent trials (1 shown)